Pharmaceutical formulation comprising a peptide angiogenesis...

Details Pharmaceutical formulation comprising a peptide angiogenesis... Pharmaceutical formulation comprising a peptide angiogenesis...

2003-06-06

2008-10-07

Weber, Jon P (Department: 1652)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S328000

Reexamination Certificate

active

07432245

ABSTRACT:
Parenteral formulations of peptides which are useful for sustained release are disclosed. Also disclosed are methods of preparation for the formulations.

REFERENCES:
patent: 4938763 (1990-07-01), Dunn et al.
patent: 5780044 (1998-07-01), Yewey et al.
patent: 5945115 (1999-08-01), Dunn et al.
patent: 5990194 (1999-11-01), Dunn et al.
patent: 6130200 (2000-10-01), Brodbeck et al.
patent: 6143314 (2000-11-01), Chandrashekar et al.
patent: 6261583 (2001-07-01), Dunn et al.
patent: 0 949 905 (2001-07-01), None
patent: 92/07555 (1992-05-01), None
patent: 99/61476 (1999-12-01), None
patent: 00/74650 (2000-12-01), None
patent: 01/35929 (2001-05-01), None

Affiliated with

Also associated with

Rating

Pharmaceutical formulation comprising a peptide angiogenesis... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical formulation comprising a peptide angiogenesis..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulation comprising a peptide angiogenesis... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3990661